Researchers reported on Tuesday that rates of colorectal and other gastrointestinal cancers are increasing among Americans under 50. The reason behind this trend may lie in rising obesity rates, which scientists believe is a significant factor contributing to early-onset gastrointestinal cancers. A study from 2019 highlighted that women classified as obese had nearly double the risk of developing early colorectal cancer. Alarmingly, projections suggest that nearly half of U.S. adults could be obese by 2030.
The relationship between obesity and cancer risk is complex. Chronic conditions, like obesity, lead to inflammation and elevated insulin levels, both of which can increase cancer risks, including various gastrointestinal types. Additional risk factors also include smoking, alcohol consumption, and dietary patterns associated with Western lifestyles.
New findings earlier this year have pointed to a gut toxin known as colibactin, which is produced by E. coli bacteria and can damage DNA in colon cells, potentially leading to cancer. However, the exact cause behind the rise in cases remains unclear, with researchers noting that this issue is not isolated to the U.S.
Dr. Sara Char from Boston’s Dana-Farber Cancer Institute emphasized that the incidence of gastrointestinal cancers in adults younger than 50 is rising worldwide.
In the U.S., data indicates a significant increase in early-onset cases since the mid-1990s, affecting both men and women. The risk of developing colon cancer has doubled for those born in 1990 compared to those born in 1950, and the risk of rectal cancer has increased fourfold. Colorectal cancer is now the primary cause of cancer-related deaths in men under 50, and the second for women in that age group. Furthermore, it disproportionately affects Black, Hispanic, Indigenous, and Asian populations.
These findings raise concerns about the need for revised treatment protocols. Patients under 50 often face delays in diagnosis, as symptoms may not initially suggest cancer, resulting in later-stage diagnoses. Younger patients frequently receive aggressive treatments that may not provide significant survival benefits.
Colorectal cancer ranks as the third-leading cause of cancer-related deaths among American men and the fourth among women, anticipated to cause around 52,900 deaths this year, according to the American Cancer Society.
It’s worth noting that younger patients often endure financial challenges, issues with body image, and mental health concerns stemming from their diagnoses, alongside a diminished quality of life. Dr. Char asserted the importance of ongoing research into early-onset GI cancers to develop better screening, prevention, and treatment strategies.
The paper detailing these findings was published in the journal BJS by Oxford University Press.
